A phase I trial of recobinant human interleukin-11 (Neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy

Saved in:

Bibliographic Details
Published in:	Blood Vol. 87; no. 9; pp. 3615 - 3624
Main Authors:	GORDON, M. S, MCCASKILL-STEVENS, W. J, SLEDGE, G. W, BATTIATO, L. A, LOEWY, J, LOESCH, D, BREEDEN, E, HOFFMAN, R, BEACH, K. J, KUCA, B, KAYE, J
Format:	Journal Article
Language:	English
Published:	Washington, DC The Americain Society of Hematology 1996
Subjects:	Biological and medical sciences Drug toxicity and drugs side effects treatment Medical sciences Pharmacology. Drug treatments Toxicity: blood Antineoplastic agent Human Thrombocytopenia Drug combination Toxicity Interleukin 11 Hemopathy Malignant tumor Dose activity relation Prevention Mammary gland diseases Chemotherapy Platelet Phase I trial Female Subcutaneous administration Mammary gland Recombinant protein Platelet derived growth factor
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!